Trapping metastatic cancer cells with mechanical ratchet arrays
Source abstract
Abstract
Current treatments for cancer, such as chemotherapy, radiotherapy, immunotherapy, and surgery, have positive results but are generally ineffective against metastatic tumors. Treatment effectiveness can be improved by employing bioengineered cancer traps, typically utilizing chemoattractant-loaded materials, to attract infiltrating cancer cells preventing their uncontrolled spread and potentially enabling eradication. However, the encapsulated chemical compounds can have adverse effects on other cells causing unwanted responses, and the generated gradients can evolve unpredictably. Here, we report the development of a cancer trap based on mechanical ratchet structures to capture metastatic cells. The traps use an array of asymmetric local features to mechanically attract cancer cells and direct their migration for prolonged periods. The trapping efficiency was found to be greater than isotropic or inverse anisotropic ratchet structures on either disseminating cancer cells and tumor spheroids. Importantly, the traps exhibited a reduced effectiveness when targeting non-metastatic and non-tumorigenic cells, underscoring their particular suitability for capturing highly invasive cancer cells. Overall, this original approach may have therapeutic implications for fighting cancer, and may also be used to control cell motility for other biological processes. STATEMENT OF SIGNIFICANCE: Current cancer treatments have limitations in treating metastatic tumors, where cancer cells can invade distant organs. Biomaterials loaded with chemoattractants can be implanted to attract and capture metastatic cells preventing uncontrolled spread. However, encapsulated chemical compounds can have adverse effects on other cells, and gradients can evolve unpredictably. This paper presents an original concept of "cancer traps" based on using mechanical ratchet-based structures to capture metastatic cancer cells, with greater trapping efficiency and stability than previously studied methods. This innovative approach has significant potential clinical implications for fighting cancer, particularly in treating metastatic tumors. Additionally, it could be applied to control cell motility for other biological processes, opening new possibilities for biomedicine and tissue engineering.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Cellular Mechanics and Interactions · Microtubule and mitosis dynamics · Microfluidic and Bio-sensing Technologies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Tissue-engineered models of human tumors for cancer research10.1517/17460441.2015.1009442 ↗
2. Forecast cancer: the importance of biomimetic 3D in vitro models in cancer drug testing/discovery and therapy10.1007/s44164-022-00014-z ↗
3. Shining a light on cancer—photonics in microfluidic tumor modeling and biosensing
4. Peptide-modified dendrimer nanoparticles for targeted therapy of colorectal cancer10.1002/adtp.201900132 ↗
5. Organ-on-chip models of cancer metastasis for future personalized medicine: From chip to the patient10.1016/j.biomaterials.2017.10.005 ↗
6. Emerging microfluidic and biosensor technologies for improved cancer theranostics
7. Bioprinting decellularized breast tissue for the development of three-dimensional breast cancer models10.1021/acsami.2c00920 ↗
8. Cancer immune therapy using engineered ‛tail-flipping’ nanoliposomes targeting alternatively activated macrophages10.1038/s41467-022-32091-9 ↗
9. Cancer traps: implantable and on-chip solutions for early cancer detection and treatment10.1002/admt.202300491 ↗
10. Reversing the tumor target: establishment of a tumor trap
11. Precision biomaterials in cancer theranostics and modelling
12. Tissue engineering a surrogate niche for metastatic cancer cells10.1016/j.biomaterials.2015.01.076 ↗
13. Enhanced survival with implantable scaffolds that capture metastatic breast cancer cells in vivo10.1158/0008-5472.CAN-15-2106 ↗
14. In vivo capture and label-free detection of early metastatic cells10.1038/ncomms9094 ↗
15. Guiding intracortical brain tumour cells to an extracortical cytotoxic hydrogel using aligned polymeric nanofibres10.1038/nmat3878 ↗
16. 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood10.1007/s10544-010-9485-3 ↗
17. A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter10.1158/0008-5472.CAN-10-0686 ↗
18. Detection of cancer cells in whole blood using a dynamic deformable microfilter and a nucleic acid aptamer10.1016/j.talanta.2021.122239 ↗
19. Filter-based isolation, enrichment, and characterization of circulating tumor cells10.1002/bit.26787 ↗
20. Rapidly responsive silk fibroin hydrogels as an artificial matrix for the programmed tumor cells death10.1371/journal.pone.0194441 ↗
21. Thermo-responsive imprinted hydrogel with switchable sialic acid recognition for selective cancer cell isolation from blood10.1016/j.bioactmat.2020.10.008 ↗
22. Controlling cancer cell fate using localized biocatalytic self-assembly of an aromatic carbohydrate amphiphile10.1021/ja5111893 ↗
23. Ratchetaxis: long-range directed cell migration by local cues10.1016/j.tcb.2015.10.009 ↗
24. Motion in microfluidic ratchets10.1039/C6LC90107G ↗
25. Protrusion fluctuations direct cell motion10.1016/j.bpj.2014.05.002 ↗
26. Cells as active particles in asymmetric potentials: motility under external gradients10.1016/j.bpj.2014.08.001 ↗
27. Ratchetaxis in channels: entry point and local asymmetry set cell directions in confinement10.1016/j.bpj.2020.08.028 ↗
28. The cell ratchet: interplay between efficient protrusions and adhesion determines cell motion10.1080/19336918.2015.1061865 ↗
29. The biophysics of cell migration: biasing cell motion with Feynman ratchets10.35459/tbp.2020.000150 ↗
30. Directing cell motions on micropatterned ratchets10.1038/nphys1306 ↗
31. Assessment of a nuclear affinity labeling method for tracking implanted mesenchymal stem cells10.3727/096368908786576444 ↗
32. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model10.1161/01.cir.0000089186.09692.fa ↗
33. Collective dynamics of focal adhesions regulate direction of cell motion
34. Cell separation based on size and deformability using microfluidic funnel ratchets10.1039/c2lc21045b ↗
35. A microfabricated deformability-based flow cytometer with application to malaria10.1039/c0lc00472c ↗
36. Directing cell migration in continuous microchannels by topographical amplification of natural directional persistence10.1016/j.biomaterials.2012.09.071 ↗
37. Micropatterning different cell types with microarray amplification of natural directional persistence10.1002/adhm.201200141 ↗
38. Chemokine releasing particle implants for trapping circulating prostate cancer cells
39. Preparation of a novel injectable in situ-gelling nanoparticle with applications in controlled protein release and cancer cell entrapment10.1039/C8RA06589F ↗
40. Geometric friction directs cell migration10.1103/PhysRevLett.111.198101 ↗
41. Nuclear envelope breakdown proceeds by microtubule-induced tearing of the lamina10.1016/S0092-8674(01)00627-4 ↗
42. Topotaxis: a new mechanism of directed cell migration in topographic ECM gradients10.1016/j.bpj.2017.11.3813 ↗
43. Tumor-associated protrusion fluctuations as a signature of cancer invasiveness10.1002/adbi.202101019 ↗
44. Analysis of the optical confinement factor in semiconductor lasers10.1063/1.361809 ↗
45. Evaluation of 2′,4′-dihydroxy-3,4,5-trimethoxychalcone as antimitotic agent that induces mitotic catastrophe in MCF-7 breast cancer cells10.1016/j.toxlet.2014.06.016 ↗
46. Beyond taxanes: a review of novel agents that target mitotic tubulin and microtubules, kinases, and kinesins
47. Serum-reduced media impacts on cell viability and protein expression in human lung epithelial cells10.1002/jcp.27890 ↗